BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2389771)

  • 1. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
    Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
    Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different expression of CD36 antigen molecule on the surface of megakaryocyte lineage leukemias and megakaryocyte leukemia cell lines MEG-01 and HEL.
    Imamura N; Mtasiwa DM; Inada T; Kuramoto A
    Leukemia; 1990 Jul; 4(7):525-8. PubMed ID: 1695706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD9 (p24) antigen on hematopoietic cells following treatment with phorbol ester.
    Yasukawa M; Hato T; Inatsuki A; Kobayashi Y
    Acta Haematol; 1988; 79(3):133-6. PubMed ID: 3128036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic GpIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia.
    Selleri C; Alfinito F; Del Vecchio L; Luciano L; De Renzo A; Rotoli B
    Leuk Lymphoma; 1993 Aug; 10(6):497-500. PubMed ID: 8401187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD9 antigen on normal activated human B cells.
    Zeleznik-Le NJ; Metzgar RS
    Cell Immunol; 1989 Oct; 123(1):70-82. PubMed ID: 2673548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies--II. Acute megakaryoblastic and acute pro-megakaryocytic leukemias.
    Imamura N; Kajihara H; Kuramoto A
    Leuk Res; 1988; 12(4):279-89. PubMed ID: 3163741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes of blasts in acute erythroblastic and megakaryoblastic leukemia--review.
    Breton-Gorius J
    Keio J Med; 1987 Jan; 36(1):23-45. PubMed ID: 3302500
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: increment of the receptor by megakaryocyte differentiation in vitro.
    Imamura N; Ota H; Abe K; Kuramoto A
    Am J Hematol; 1994 Feb; 45(2):181-4. PubMed ID: 7511332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
    Matsumoto K; Anasetti C
    Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters.
    Ogura M; Morishima Y; Okumura M; Hotta T; Takamoto S; Ohno R; Hirabayashi N; Nagura H; Saito H
    Blood; 1988 Jul; 72(1):49-60. PubMed ID: 2455575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD9 antibodies augment neutrophil adherence to endothelium.
    Forsyth KD
    Immunology; 1991 Feb; 72(2):292-6. PubMed ID: 2016123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen.
    Morrish DW; Shaw AR; Seehafer J; Bhardwaj D; Paras MT
    In Vitro Cell Dev Biol; 1991 Apr; 27A(4):303-6. PubMed ID: 1856155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.
    Morita S; Tsuchiya S; Fujie H; Itano M; Ohashi Y; Minegishi M; Imaizumi M; Endo M; Takano N; Konno T
    Leukemia; 1996 Jan; 10(1):102-5. PubMed ID: 8558913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the CD4 molecule on acute nonlymphocytic leukemia (ANLL) cell lines.
    Neudorf S; DeLaat C; Jones M
    J Clin Lab Anal; 1989; 3(5):312-5. PubMed ID: 2809881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
    Lagaudrière-Gesbert C; Le Naour F; Lebel-Binay S; Billard M; Lemichez E; Boquet P; Boucheix C; Conjeaud H; Rubinstein E
    Cell Immunol; 1997 Dec; 182(2):105-12. PubMed ID: 9514697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding of CD9 antigen in acute lymphoblastic leukemia.
    Komada Y; Sakurai M
    Leuk Lymphoma; 1994 Feb; 12(5-6):365-72. PubMed ID: 8180600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.
    Peterson BA; Levine EG
    Semin Oncol; 1987 Dec; 14(4):425-34. PubMed ID: 3321447
    [No Abstract]   [Full Text] [Related]  

  • 20. CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype.
    Ferrero D; Carlesso N; Gallo E; Pregno P; De Fabritiis P; Petti MC; Mandelli F
    Leuk Res; 1991; 15(6):457-61. PubMed ID: 1861531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.